Gilead Sciences
GILD
NASDAQ
IPO1992
about GILD
Gilead Sciences develops innovative pharmaceuticals to treat conditions such as HIV/AIDS, hepatitis C, and other serious diseases.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $119.77 | $120.28 | $118.23 | $149.48B | 1.78M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$1.57 | 24.28 | 21.04 | 34.93% | 27.68% | 2.66% |